Historical record - last NADAC effective date: 6/11/2014
Product Information
NAPRELAN CR 375 MG TABLET is a brand product labeled by Almatica Pharma LLC, priced at $17.8402 per EA under NDC 52427027201. Its NADAC has been published 23 times since Jun 11, 2014.
FDA first approved this application on Jan 5, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Naproxen Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
375 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427027201
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
6/11/2014
Active Ingredients
NAPROXEN SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA020353FDA Approved
1/5/1996
TE Code
AB
On Market Since
1/17/2014
Pharmacological Classes
Price Statistics
The NADAC for NAPRELAN CR 375 MG TABLET has been published 23 times since Jun 11, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $17.8402 per EA |
|---|---|
| All-time high | $17.8402 (Nov 12, 2014) |
| All-time low | $17.8402 (Jun 11, 2014) |
| Median price | $17.8402 |
| Average price | $17.8402 |
| Largest weekly change | 0.0% (Jun 18, 2014) |
| Weeks tracked | 23 |
| Tracking since | Jun 11, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Nov 12, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naproxen Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NAPRELAN CR 375 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPRELAN CR 375 MG TABLET, manufactured by Almatica Pharma LLC, is $17.8402 per EA (NDC 52427027201), effective Nov 12, 2014.
How has the price of NAPRELAN CR 375 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPRELAN CR 375 MG TABLET has held within roughly two percent of its current level. It has been tracked across 23 weekly CMS publications since Jun 11, 2014.
What are the highest and lowest recorded NADAC prices for NAPRELAN CR 375 MG TABLET?
Since Jun 11, 2014, the NADAC for NAPRELAN CR 375 MG TABLET has ranged from a low of $17.8402 (Jun 11, 2014) to a high of $17.8402 (Nov 12, 2014), with a median of $17.8402 per EA.
Are there cheaper alternatives to NAPRELAN CR 375 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NAPRELAN CR 375 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NAPRELAN CR 375 MG TABLET?
NAPRELAN CR 375 MG TABLET (NDC 52427027201) is labeled by Almatica Pharma LLC, and CMS classifies it as a brand product.